Leucovorin lacks evidence to use as autism treatment, FDA says
The FDA approves leucovorin for a rare brain disorder while retreating from top officials’ earlier insistence that it could benefit many children with autism.
The FDA approves leucovorin for a rare brain disorder while retreating from top officials’ earlier insistence that it could benefit many children with autism.
A new study published in the Journal American Medical Association showed that patients with an Cystatin C based estimated glomerular filtration rates (eGFR) value at least 30% lower than their…
Researchers have found in a new study that the hemoglobin, albumin, lymphocyte, and platelet score serves as an independent predictor of 30-day readmission in patients with acute exacerbation of chronic…
University of Pittsburgh School of Medicine researchers have developed an early-stage, experimental “living eye drop” that uses naturally occurring eye bacteria to support corneal wound healing. The proof-of‑concept study, published…
It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different practices.
Women with metastatic breast cancer often face multiple chronic conditions, and high blood pressure is among the most common. Nearly half of women in this study population had hypertension at…
A new study published in the Journal of Periodontology showed that over a 4-year period, tooth loss was linked to increased weight gain. Pairs of opposing posterior teeth that support…
AI scribe company Nabla aims to be much more by using tech from Yann LeCun's new startup AMI, which just raised $1 billion.
The co-founders of the Covid-19 vaccine developer BioNTech plan to leave the biotech to start a new mRNA-focused company
Gurgaon: In a shocking incident, a woman suffered more than 25% burn injuries after a man allegedly threw acid on her inside the casualty ward of Civil Hospital, Sector 10,…